PSANEUTRAL

PEG Ratio

1.13x

Updated 128h ago

Sector Performance

55th percentile

PSA

1.13x

Sector Median

0.94x

Sector Avg

3.01x

📊

Deep Analysis

The current PEG ratio of 1.13x – the price-to-earnings ratio divided by the expected earnings growth rate – means the stock’s price is a bit higher than its growth prospects would justify, so it is not a clear bargain.

This is above the sector median of 0.97x, placing PSA in the 54th percentile among its peers, meaning about half of sector stocks have lower PEGs. Year-over-year change is not available, but quarter-over-quarter the ratio has risen by 9.7%, indicating that either the price increased or expected growth slowed relative to the prior quarter. The combination of a PEG above the sector median and a rising trend suggests the stock may be getting relatively more expensive, which typically implies some caution for value-focused investors. This metric does not directly conflict with the overall NEUTRAL verdict – it aligns with a view that the stock is fairly valued neither cheap nor overvalued – but the upward move bears monitoring.

Frequently Asked Questions

What does the PEG Ratio tell investors about PSA?

The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.

How is the PEG Ratio calculated?

PEG Ratio is calculated as: P/E Ratio / EPS Growth Rate.

Who are PSA's closest peers by PEG Ratio?

The closest peers by PEG Ratio include: NUE (0.06x), VLO (0.06x), LNC (0.05x), NKE (0.05x), NCLH (0.05x).

The Formula

P/E Ratio / EPS Growth Rate

Why It Matters

The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.

Advertisement

Master PSA's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full PSA research report

Free account — no credit card

PSA

1.13x

Sector Median

0.94x

Sector Avg

3.01x

How PSA's PEG Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.